Public Employees Retirement Association Of Colorado Biotechnology

Public Employees Retirement Association Of Colorado

$25.9 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
FOLD Amicus Therapeutics, Inc.	$2.21B	$173,000 0.0% of portfolio	30,145	Q2 2024 Reduced 10.63%
DNLI Denali Therapeutics Inc.	$2.06B	$171,000 0.0% of portfolio	12,238	Q3 2023 Added 7.43%
TVTX Travere Therapeutics, Inc.	$1.36B	$160,000 0.0% of portfolio	10,796	Q3 2023 Added 84.36%
CLDX Celldex Therapeutics, Inc.	$1.09B	$158,000 0.0% of portfolio	7,787	Q1 2024 New
SRPT Sarepta Therapeutics, Inc.	$1.54B	$155,000 0.0% of portfolio	9,066	Q2 2024 Reduced 9.54%
APLS Apellis Pharmaceuticals, Inc.	$2.95B	$145,000 0.0% of portfolio	8,362	Q1 2024 Reduced 14.23%
ADPT Adaptive Biotechnologies Corp	$1.79B	$144,000 0.0% of portfolio	12,322	Q3 2023 Reduced 28.91%
SNDX Syndax Pharmaceuticals Inc	$924M	$129,000 0.0% of portfolio	13,746	Q2 2024 Reduced 15.27%
TBPH Theravance Biopharma, Inc.	$930M	$120,000 0.0% of portfolio	10,856	Q3 2023 Reduced 74.0%
IMVT Immunovant, Inc.	$3.55B	$107,000 0.0% of portfolio	6,698	Q3 2023 Reduced 79.17%
BEAM Beam Therapeutics Inc.	$1.43B	$106,000 0.0% of portfolio	6,230	Q3 2023 Added 735.12%
ARDX Ardelyx, Inc.	$1.01B	$96,000 0.0% of portfolio	24,496	Q2 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$1.04B	$92,000 0.0% of portfolio	6,577	Q3 2024 New
NTLA Intellia Therapeutics, Inc.	$903M	$92,000 0.0% of portfolio	9,760	Q3 2023 Reduced 98.47%
VERA Vera Therapeutics, Inc.	$669M	$88,000 0.0% of portfolio	3,718	Q2 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$834M	$87,000 0.0% of portfolio	17,217	Q2 2024 New
SAGE Sage Therapeutics, Inc.	$516M	$82,000 0.0% of portfolio	8,938	Q3 2023 Reduced 45.43%
GERN Geron Corp	$518M	$77,000 0.0% of portfolio	54,913	Q2 2024 Reduced 38.8%
XNCR Xencor Inc	$502M	$73,000 0.0% of portfolio	9,276	Q3 2023 Reduced 77.58%
NUVB Nuvation Bio Inc.	$758M	$58,000 0.0% of portfolio	29,841	Q2 2024 Reduced 17.84%
DYN Dyne Therapeutics, Inc.	$688M	$55,000 0.0% of portfolio	5,740	Q2 2024 New
KURA Kura Oncology, Inc.	$545M	$55,000 0.0% of portfolio	9,545	Q2 2024 Reduced 15.49%
VIR Vir Biotechnology, Inc.	$695M	$55,000 0.0% of portfolio	10,862	Q3 2023 Reduced 2.43%
NVAX Novavax Inc	$623M	$50,000 0.0% of portfolio	7,873	Q3 2023 Reduced 5.37%
RGNX Regenxbio Inc.	$410M	$50,000 0.0% of portfolio	6,040	Q3 2023 Reduced 94.68%
PRTA Prothena Corp Public LTD CO	$391M	$40,000 0.0% of portfolio	6,552	Q3 2023 Reduced 28.78%
EWTX Edgewise Therapeutics, Inc.	$940M	$37,000 0.0% of portfolio	2,849	Q3 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$350M	$37,000 0.0% of portfolio	15,511	Q3 2023 Added 232.35%
CDXS Codexis, Inc.	$160M	$33,000 0.0% of portfolio	13,643	Q2 2024 Reduced 3.73%
IOVA Iovance Biotherapeutics, Inc.	$376M	$29,000 0.0% of portfolio	16,764	Q4 2020 Reduced 10.36%
ARVN Arvinas, Inc.	$422M	$26,000 0.0% of portfolio	3,526	Q3 2023 Reduced 76.47%
REPL Replimune Group, Inc.	$298M	$25,000 0.0% of portfolio	2,712	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$489M	$20,000 0.0% of portfolio	5,888	Q3 2023 Reduced 82.71%
RCKT Rocket Pharmaceuticals, Inc.	$247M	$20,000 0.0% of portfolio	8,193	Q3 2023 Reduced 70.58%
COGT Cogent Biosciences, Inc.	$834M	$16,000 0.0% of portfolio	2,198	Q3 2024 New
IBRX Immunity Bio, Inc.	$965M	$15,000 0.0% of portfolio	5,517	Q3 2024 New
CGEM Cullinan Oncology, Inc.	$312M	$9,000 0.0% of portfolio	1,150	Q3 2024 New
JANX Janux Therapeutics, Inc.	$1.03B	$4,000 0.0% of portfolio	172	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.